Janney Montgomery Scott
JAZZ icon

Janney Montgomery Scott’s Jazz Pharmaceuticals JAZZ Stock Holding History

Janney Montgomery Scott’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-23,878
Closed -$4.06M – 2914
2025
Q4 		$4.06M Buy
23,878
+11,117
+87% +$1.7M 0.01% 996
2025
Q3 		$1.68M Sell
12,761
-2,194
-15% -$263K ﹤0.01% 1402
2025
Q2 		$1.59M Sell
14,955
-255
-2% -$27.7K ﹤0.01% 1316
2025
Q1 		$1.89M Buy
+15,210
New +$1.98M 0.01% 1185
2024
Q4 		– Sell
-10,266
Closed -$1.14M – 2774
2024
Q3 		$1.14M Sell
10,266
-656
-6% -$71.9K ﹤0.01% 1425
2024
Q2 		$1.17M Sell
10,922
-4,966
-31% -$546K ﹤0.01% 1360
2024
Q1 		$1.91M Buy
15,888
+4,939
+45% +$605K 0.01% 1172
2023
Q4 		$1.35M Buy
10,949
+3,591
+49% +$448K ﹤0.01% 1287
2023
Q3 		$952K Buy
+7,358
New +$980K ﹤0.01% 1370
2021
Q3 		– Sell
-24,759
Closed -$4.4M – 2335
2021
Q2 		$4.4M Buy
+24,759
New +$4.29M 0.02% 633
2019
Q4 		– Sell
-4,562
Closed -$585K – 2108
2019
Q3 		$585K Sell
4,562
-2,622
-36% -$351K ﹤0.01% 1297
2019
Q2 		$1.02M Buy
7,184
+401
+6% +$53.9K 0.01% 1039
2019
Q1 		$970K Sell
6,783
-70
-1% -$9.13K 0.01% 1047
2018
Q4 		$849K Buy
6,853
+519
+8% +$77K 0.01% 1013
2018
Q3 		$1.06M Buy
6,334
+2,665
+73% +$458K 0.01% 995
2018
Q2 		$632K Buy
3,669
+64
+2% +$10.5K 0.01% 1261
2018
Q1 		$544K Buy
3,605
+1,619
+82% +$237K 0.01% 1290
2017
Q4 		$267K Buy
1,986
+226
+13% +$31.3K ﹤0.01% 1645
2017
Q3 		$257K Buy
1,760
+400
+29% +$60.5K ﹤0.01% 1583
2017
Q2 		$211K Buy
+1,360
New +$208K ﹤0.01% 1601
2013
Q3 		– Sell
-3,426
Closed -$235K – 1905
2013
Q2 		$235K Buy
+3,426
New +$209K 0.02% 620

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Janney Montgomery Scott's JAZZ Position: Q1 2026 in Review

Janney Montgomery Scott sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2026, closing a stake of 23,878 shares — an estimated $4.06M sold.

Janney Montgomery Scott first reported a position in JAZZ in Q2 2013 and held it in 21 quarters. The position peaked at $4.4M in Q2 2021. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Janney Montgomery Scott reported no remaining Jazz Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Janney Montgomery Scott sold 23,878 Jazz Pharmaceuticals shares in Q1 2026, an estimated $4.06M.
  • Janney Montgomery Scott first reported a position in Jazz Pharmaceuticals in Q2 2013 and held it in 21 quarters.
  • Janney Montgomery Scott's Jazz Pharmaceuticals position peaked at $4.4M in Q2 2021.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Janney Montgomery Scott's 13F filing for Q1 2026, filed 22 Apr 2026.